除了达比加特兰:承认直接口服抗凝剂是排皮性食道炎的原因
Miriam Celada-Sendino1, Margarita Fernández-de la Varga1, Carlos Ordieres-Díaz1
1UGC Aparato Digestivo, Hospital Vital Álvarez-Buylla, España.
Revista espanola de enfermedades digestivas
|June 12, 2025
概括
直接口服抗凝剂 (DOACs) 可能导致罕见的胃肠道问题,如皮性食道炎. 虽然不常见,但认识到这些副作用对于有效的患者管理至关重要.
科学领域:
- 胃肠病学 胃肠病学
- 药理学 药理学是指药理学的学科.
背景情况:
- 直接口服抗凝剂 (DOAC) 广泛用于抗凝.
- DOACs提供有效性和安全性,但可能会产生不良影响.
- 胃肠道不良事件是已知的,虽然不常见的,DOAC治疗的并发症.
研究的目的:
- 为了突出脱皮性食道炎和食道炎的发生,表面的剖析.
- 讨论这些食道疾病与DOACs的关联,特别是达比加.
- 强调临床和内镜识别对患者管理的重要性.
主要方法:
- 对与DOAC使用相关的临床病例和内镜发现的审查.
- 分析与特定的DOAC药物相关的报道不良事件.
- 关于 DOACs 的食道表现的文献综合.
主要成果:
- 脱皮性食道炎和食道炎表面剖析被确定为DOACs潜在的消化道不良影响.
- 这些特定的食道疾病主要与达比加特兰一起报告.
- 这些影响的发生率似乎与其他DOACs不常见.
结论:
- 虽然DOACs有益,但存在特定上部胃肠道不良事件的风险.
- 达比加特兰更频繁地与脱皮性食道炎和食道炎切割表面性有关.
- 及时的临床和内镜评估对于诊断和管理这些罕见的DOAC诱导的食道并发症至关重要.
相关概念视频
Anticoagulant Drugs: Vitamin K Antagonists and Direct Oral Anticoagulants
1.2K
Oral anticoagulants are vital tools in preventing and treating blood clotting disorders. This diverse class of medications can be categorized as vitamin K antagonists, exemplified by warfarin, and direct thrombin inhibitors (DTIs), such as dabigatran, as well as factor Xa inhibitors, including rivaroxaban.
Warfarin, a prominent vitamin K antagonist family member, exerts its effect by inhibiting the enzyme VKORC1 (vitamin K epoxide reductase complex 1). By hindering this enzyme, warfarin...
Warfarin, a prominent vitamin K antagonist family member, exerts its effect by inhibiting the enzyme VKORC1 (vitamin K epoxide reductase complex 1). By hindering this enzyme, warfarin...
1.2K
Anticoagulant Drugs: Low-Molecular-Weight Heparins
649
Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
649
Esophageal Varices-I: Introduction
85
Esophageal varices are dilated, tortuous veins which are found mainly in the submucosa of the lower esophagus but which may also appear higher up or extend into the stomach. They develop due to increased pressure in the portal venous system, often as a result of liver cirrhosis. This condition scars and damages the liver, impeding normal blood flow through the portal vein. To compensate, blood seeks alternative pathways, forming fragile new vessels (varices) in the esophagus and stomach. These...
85
Barrett Esophagus-II: Clinical Manifestations and Management
121
Individuals with Barrett's esophagus are often asymptomatic, but they may experience symptoms commonly associated with GERD, such as heartburn and acid regurgitation. Additional symptoms can include difficulty swallowing, chest pain, unintentional weight loss, blood in the stool (which may appear black, tarry, or bloody), and episodes of vomiting.
To diagnose Barrett's esophagus, healthcare providers often recommend an endoscopy for those showing symptoms of acid reflux. The procedure...
To diagnose Barrett's esophagus, healthcare providers often recommend an endoscopy for those showing symptoms of acid reflux. The procedure...
121
Drugs for Peptic Ulcer Disease: Sucralfate as Mucosal Protective Agents
414
In the intricate landscape of the gastric lumen, excessive acid secretion disrupts the natural defense mechanisms, weakening the mucus-bicarbonate barrier. This vulnerability allows pepsin to infiltrate epithelial cells, digesting mucosal proteins and triggering erosion, leading to ulcer formation.
In this scenario, mucosal protective agents like sucralfate play an essential role. Sucralfate, a complex of sulfated sucrose and aluminum hydroxide, demonstrates its usefulness in acidic conditions,...
In this scenario, mucosal protective agents like sucralfate play an essential role. Sucralfate, a complex of sulfated sucrose and aluminum hydroxide, demonstrates its usefulness in acidic conditions,...
414
Peptic Ulcer Disease IV: Management
74
Medical treatment strategies for peptic ulcers encompass various methods. The primary goal of treatment is to diminish gastric acidity and strengthen mucosal defense mechanisms.
The therapeutic approach involves ensuring adequate rest, implementing drug therapy, promoting smoking cessation, making dietary modifications, and emphasizing long-term follow-up care.
Pharmacological management
The prevailing therapy for peptic ulcers involves a combination of managing the patient's current...
The therapeutic approach involves ensuring adequate rest, implementing drug therapy, promoting smoking cessation, making dietary modifications, and emphasizing long-term follow-up care.
Pharmacological management
The prevailing therapy for peptic ulcers involves a combination of managing the patient's current...
74


